BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-70@pharmaconomics
DTSTAMP:20260707T021628Z
DTSTART;VALUE=DATE:20270226
DTEND;VALUE=DATE:20270227
SUMMARY:ALXN Phase 3 — Tenapanor 5 mg BID
DESCRIPTION:Phase 3 trial results for Tenapanor 5 mg BID in Chronic Idiopathic Constipation (CIC) are due Feb 26\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT07382167\n\nTrack it: https://pharmaconomics.com/e/70
URL:https://pharmaconomics.com/e/70
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ALXN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR